Skip to main content
. 2010 Mar 17;2010(3):CD006114. doi: 10.1002/14651858.CD006114.pub2

5.19. Analysis.

5.19

Comparison 5 Fluvoxamine versus newer ADs, Outcome 19 Sensitivity analysis ‐ Response (acute phase) 8. Excluding trials that might include patients with bipolar depression.